COMPOSITIONS AND METHODS FOR COMBINATION ANTIVIRAL THERAPY

European Patent Office Patent

APP PUB NO EP-1585527-A1
SERIAL NO

04701840

Stats

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to therapeutic combinations of [9-[R-2-[[(S)-[[(S)-1-(isopropoxycarbonyl)ethyl]amino]-phenoxyphosphinyl]methoxy]propyl]adenine(GS-7340) and (2R, 5S, cis)-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one (emtricitabine,(-)-cis FTC, EmtrivaTM and their physiologically functional derivatives. The combinations may be useful in the treatment of HIV infections, including infections with HIV mutants bearing resistance to nucleoside and/or non-nucleoside inhibitors. The present invention is also concerned with pharmaceutical compositions and formulations of said combinations of GS-7340 and emtricitabine, and their physiologically functional derivatives, as well as therapeutic methods of use of those compositions and formulations.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GILEAD SCIENCES INCUS333 LAKESIDE DRIVE FOSTER CITY CALIFORNIA 94404 UNITED STATES OF AMERICA

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address
DAHL TERRENCE C SUNNYVALE CA
MENNING MARK M FOSTER CITY CA
OLIYAI REZA BURLINGAME CA

Cited Art Landscape

Load Citation